Carl Zeiss Meditec AG

Carl Zeiss Meditec AG has demonstrated remarkable resilience in the face of global market challenges, maintaining its course towards ambitious annual targets through strategic partnerships, market expansion, and operational excellence.

Carl Zeiss Meditec AG navigates challenges and opportunities in 2025, driven by strategic partnerships, innovation, and a focus on emerging markets, despite uncertainties in key markets like China and the USA.

Carl Zeiss Meditec AG reported a 10.9% revenue increase to €1.050.5 million in the first half of 2024/25, driven by strategic acquisitions, but faces challenges in China and the USA.

Carl Zeiss Meditec AG is undergoing a leadership change, with CEO Markus Weber stepping down and Maximilian Foerst, head of ZEISS Greater China, set to take over as CEO.